Enrico Cerrato Selected Research

Percutaneous Coronary Intervention

1/2022	Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study.
1/2022	Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.
1/2022	Letter by Cerrato and Escaned Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial".
12/2021	Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries.
8/2021	Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry.
1/2021	Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
9/2020	Impact of the metal-to-artery ratio on clinical outcomes in left main and nonleft main bifurcation: insights the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
1/2020	Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.
1/2020	Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
1/2020	[Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrico Cerrato Research Topics

Disease

46	Myocardial Infarction 11/2022 - 06/2011
38	Thrombosis (Thrombus) 01/2022 - 06/2011
22	Acute Coronary Syndrome 11/2022 - 04/2012
18	Hemorrhage 11/2022 - 05/2015
17	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 04/2013
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2016
9	Stroke (Strokes) 01/2022 - 06/2011
9	ST Elevation Myocardial Infarction 01/2022 - 01/2015
8	Pathologic Constriction (Stenosis) 06/2022 - 05/2015
8	COVID-19 01/2022 - 01/2021
8	Hypertension (High Blood Pressure) 01/2022 - 01/2015
6	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
5	Sepsis (Septicemia) 02/2022 - 01/2020
5	Spontaneous Coronary Artery Dissection 01/2022 - 07/2017
5	Death (Near-Death Experience) 12/2018 - 06/2011
4	Renal Insufficiency (Renal Failure) 01/2022 - 01/2021
4	Hypersensitivity (Allergy) 01/2022 - 10/2015
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2018 - 04/2014
3	Atrial Fibrillation 08/2021 - 02/2017
3	Diabetes Mellitus 09/2019 - 01/2014
3	Heart Failure 08/2017 - 12/2008
2	Renal Hypertension 08/2021 - 01/2020
2	Obesity 05/2021 - 01/2021
2	Lymphopenia (Lymphocytopenia) 05/2021 - 01/2021
2	Unstable Angina 10/2020 - 03/2015
2	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2020 - 02/2017
2	Non-ST Elevated Myocardial Infarction 08/2019 - 11/2017
2	HIV Infections (HIV Infection) 12/2015 - 09/2014
2	Coronary Disease (Coronary Heart Disease) 01/2014 - 04/2013
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2022
1	Vomiting 01/2022
1	Coronary Aneurysm (Aneurysm, Coronary) 01/2022
1	Aneurysm (Aneurysms) 11/2021
1	Anosmia 08/2021
1	Dyslipidemias (Dyslipidemia) 08/2021
1	Heart Neoplasms 08/2021
1	Infarction (Infarctions) 08/2021
1	Tachypnea 05/2021
1	Dyspnea (Shortness of Breath) 05/2021
1	Neoplasms (Cancer) 05/2021
1	Lung Diseases (Lung Disease) 04/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Frailty 01/2021
1	Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Chronic Renal Insufficiency 09/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Bicuspid Aortic Valve Disease 01/2020
1	Ischemia 01/2020

Drug/Important Bio-Agent (IBA)

29	omega-Chloroacetophenone (Mace)IBA 01/2022 - 04/2013
15	TicagrelorIBA 11/2022 - 01/2017
12	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2022 - 05/2015
12	Prasugrel Hydrochloride FDA Link 11/2022 - 01/2018
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 01/2014
6	Clopidogrel (Plavix)FDA Link 11/2022 - 05/2015
5	C-Reactive ProteinIBA 08/2021 - 05/2013
4	MagnesiumIBA 01/2022 - 11/2017
3	CreatinineIBA 11/2021 - 04/2019
2	Oxygen (Dioxygen)IBA 02/2022 - 04/2021
2	indobufenIBA 01/2022 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021 - 01/2014
2	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2020
2	TroponinIBA 01/2021 - 01/2014
2	Everolimus FDA Link 06/2016 - 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	cangrelorIBA 01/2022
1	InterferonsIBA 11/2021
1	Angiotensin Receptor AntagonistsIBA 11/2021
1	BenzodiazepinesIBA 11/2021
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	SmokeIBA 08/2021
1	factor AIBA 08/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	fibrin fragment D (D-dimer)IBA 04/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	MetalsIBA 09/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	BESIBA 01/2020
1	PolymersIBA 01/2020
1	SodiumIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Purinergic P2Y Receptor AntagonistsIBA 03/2019

Therapy/Procedure

39	Stents 01/2022 - 06/2011
32	Therapeutics 11/2022 - 04/2012
24	Percutaneous Coronary Intervention 01/2022 - 04/2012
11	Drug-Eluting Stents 06/2022 - 05/2016
5	Transcatheter Aortic Valve Replacement 01/2021 - 04/2014
3	Noninvasive Ventilation 05/2021 - 08/2017
3	Highly Active Antiretroviral Therapy (HAART) 12/2015 - 04/2012
2	Artificial Respiration (Mechanical Ventilation) 02/2022 - 01/2021
2	Duration of Therapy 10/2021 - 02/2017
1	Bridge Therapy 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Emergency Treatment 01/2022
1	Catheters 08/2021
1	Critical Care (Surgical Intensive Care) 05/2021
1	Conservative Treatment 01/2021
1	Length of Stay 01/2021
1	Off-Label Use 01/2020